抗中性粒细胞胞质抗体相关血管炎结局测量工具的心理测量学特性:一项系统文献综述
该系统综述检索截至2020年7月14日的文献,评估抗中性粒细胞胞质抗体相关血管炎(AAV)所用结局测量工具的心理测量学特性。从2505篇文章中纳入32篇,涉及22种工具。BVAS(任何版本)、VDI和AAV-PRO的心理测量学特性最强。
要点
- BVAS/WG测量疾病活动度与医生整体评估的相关系数r=0.90,观察者间组内相关系数=0.97。
- VDI与BVAS第3版6个月时相关系数r=0.14,与BVAS/WG 1年时r=0.40、5年时r=0.20。
- AAV-PRO六个维度与EQ-5D-5L的相关系数为-0.78至-0.55,区分活动期与缓解期P<0.0001。
核心结论
- 在用于AAV的22种结局测量工具中,BVAS(任何版本)、VDI和AAV-PRO的心理测量学特性最强。
研究设计与样本
- 系统文献综述,检索Medline、EMBASE、Cochrane、Scopus和Web of Science从建库至2020年7月14日的文献,纳入AAV所用工具的验证研究。
- 从2505篇文章中纳入32篇,提供22种工具的信息,涉及疾病活动度(n=7)、损伤(n=2)、活动度与损伤(n=1)、健康相关生活质量(HRQoL;n=9)和功能(n=3)。
- 依据COSMIN和OMERACT框架总结效度、信度、反应度和可行性,并按COSMIN清单评估偏倚风险。
主要发现
- 大多数工具在AAV整体人群或仅在肉芽肿性多血管炎中测试。
- BVAS/WG测量疾病活动度有效(与医生整体评估的相关系数r=0.90),信度(观察者间组内相关系数=0.97)、反应度和可行性良好。
- VDI测量损伤具有中等效度(与BVAS第3版6个月时相关系数r=0.14,与BVAS/WG 1年时r=0.40、5年时r=0.20),且可行。
- AAV-PRO测量HRQoL显示效度(六个维度与EQ-5D-5L的相关系数为-0.78至-0.55;区分活动性疾病与缓解,所有比较P<0.0001)。
- 评估功能的工具整体性能为低至中等。
关键数值与推荐
- BVAS/WG与医生整体评估的相关系数r=0.90,观察者间组内相关系数=0.97。
- VDI与BVAS第3版6个月时相关系数r=0.14,与BVAS/WG 1年时r=0.40、5年时r=0.20。
- AAV-PRO六个维度与EQ-5D-5L的相关系数为-0.78至-0.55,区分活动期与缓解期P<0.0001。
局限性
- 大多数工具在AAV整体人群或仅在肉芽肿性多血管炎中测试。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To systematically review the psychometric properties of outcome measurement instruments used in ANCA-associated vasculitis (AAV). METHODS: Medline, EMBASE, Cochrane, Scopus and Web of Science were searched from inception to 14 July 2020 for validation studies of instruments used in AAV. Following the COnsensus-based Standards for the selection of health status Measurement INstruments (COSMIN) and OMERACT frameworks, different psychometric properties (validity, reliability, responsiveness and feasibility) were summarized. Risk of bias was assessed according to the COSMIN checklist. RESULTS: From 2505 articles identified, 32 met the predefined selection criteria, providing information on 22 instruments assessing disease activity (n = 7), damage (n = 2), activity and damage (n = 1), health-related quality of life (HRQoL; n = 9) and function (n = 3). Most of the instruments were tested in AAV as a group or in granulomatosis with polyangiitis only.The BVAS, any version, the Vasculitis Damage Index (VDI) and the AAV-Patient-Reported Outcome (AAV-PRO) have been more extensively validated than the other instruments. BVAS for Wegener Granulomatosis (BVAS/WG) has been shown to be valid for measuring disease activity [correlation with Physician global assessment (r = 0.90)], reliability (inter-observer intraclass correlation coefficient = 0.97), responsiveness and feasibility. For damage, VDI was shown to be moderately valid (correlations with BVAS version 3 at 6 months r = 0.14, BVAS/WG at 1 year r = 0.40 and 5 years r = 0.20), and feasible. For HRQoL, AAV-PRO demonstrated validity (correlations of the six AAV-PRO domains with EQ-5D-5L: -0.78 to -0.55; discrimination between active disease and remission, P < 0.0001 for all comparisons). The overall performance of instruments assessing function was low-to-moderate. CONCLUSION: Among the 22 outcome measurement instruments used for AAV, BVAS (any version), VDI and AAV-PRO had the strongest psychometric properties.
引用
- Berti A, Boleto G, Merkel PA, et al. Psychometric properties of outcome measurement instruments for ANCA-associated vasculitis: a systematic literature review. Rheumatology (Oxford). 2022. PMID: 35293985. doi:10.1093/rheumatology/keac175
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。